Related Experiment Video
Updated: Feb 14, 2026
12:08
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
13.4K
Talimogene laherparepvec: First in class oncolytic virotherapy
Robert M Conry1, Brian Westbrook2, Svetlana McKee1
1a Medicine/Division of Hematology and Oncology, University of Alabama at Birmingham , Birmingham , AL , USA.
Human Vaccines & Immunotherapeutics
|February 9, 2018
Summary
Oncolytic viruses like talimogene laherparepvec (TVEC) offer a new cancer treatment by destroying tumors and boosting immune responses. TVEC is FDA-approved for advanced melanoma, showing promise for other cancers too.
Area of Science:
- Oncolytic virotherapy
- Cancer immunotherapy
- Viral oncology
Background:
- Oncolytic viruses are a novel drug class for cancer treatment.
- Talimogene laherparepvec (TVEC) is a modified herpes simplex virus.
- TVEC selectively replicates in tumor cells, inducing tumor lysis and systemic antitumor immunity.
Purpose of the Study:
- To review the biology and mechanism of action of TVEC.
- To discuss the clinical indication of TVEC for advanced melanoma.
- To explore future directions for TVEC and other oncolytic viruses.
Main Methods:
- Review of TVEC's genetic modification and biological function.
- Analysis of clinical trial data for TVEC in advanced melanoma.
- Examination of TVEC's role in combination therapies and other malignancies.
Main Results:
- TVEC is the only oncolytic virus approved by the FDA for advanced melanoma.
- Demonstrated improved durable response rate in a randomized, phase III trial.
- Ongoing clinical trials investigate TVEC in neoadjuvant settings and combination therapies.
Conclusions:
- TVEC serves as a prototype for the growing field of oncolytic viruses.
- TVEC's mechanism involves direct tumor cell killing and immune system stimulation.
- Further research is exploring TVEC's potential across various cancers and treatment combinations.
Related Concept Videos
01:25Drug Classes and Categories
3.1K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
3.1K
01:25Antibody Structure and Classes
9.4K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
9.4K
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
1.9K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.9K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
2.0K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.0K
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
3.5K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.5K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.6K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.6K